A renowned British surgeon and academic who made significant contributions to the field of thrombosis research and treatment, improving patient outcomes worldwide.
Ajay Kakkar, Baron Kakkar, is a renowned British surgeon, researcher, and academic who has made significant contributions to the field of thrombosis research and surgery. He is particularly known for his work in promoting British business as an ambassador for the United Kingdom and his efforts to prevent venous thromboembolism (VTE) in the National Health Service (NHS).
Kakkar was born on 28 April 1964 in Dartford, England, to Professor Vijay Kakkar, a pioneer in the use of low-molecular weight heparin therapy, and his wife, a consultant anesthetist. He was educated at Alleyn's School and later gained admission to King's College London, where he earned a Bachelor's degree in Pharmacology in 1985 and a medical degree in 1988. Kakkar went on to pursue a Doctor of Philosophy (PhD) degree at Imperial College London, submitting his thesis, titled "Tissue factor, thrombin generation and cancer," in 1998.
Kakkar has had a distinguished career as a surgeon, researcher, and academic. He is currently the Chair of King's Health Partners, the Academic Health Science Centre, and Director of the Thrombosis Research Institute, London. He has worked extensively with the NHS on its strategy to prevent VTE and has lectured and published widely on his specialism. Kakkar has also served as a Commissioner of the Royal Hospital Chelsea and a Trustee of the Dulwich Estate.
Kakkar was created a life peer on 22 March 2010 as Baron Kakkar, of Loxbeare in the County of Devon, and was introduced in the House of Lords the same day. He sits on the crossbenches and has served as Chairman of the House of Lords Appointments Commission from 2013 to 2018. In 2022, Kakkar was appointed Knight Commander of the Order of the British Empire (KBE) for his services to healthcare and public service.
Kakkar's contributions to thrombosis research and surgery have had a significant impact on modern society. His work has helped to improve patient outcomes and reduce the risk of VTE in hospitals. Additionally, his efforts to promote British business have helped to boost the UK's economy and strengthen international relationships.
Kakkar's work is guided by a strong commitment to improving patient care and advancing medical research. He believes in the importance of collaboration between academia, industry, and government to drive innovation and improve healthcare outcomes.
Kakkar's life and work serve as an inspiration to many, and his contributions to thrombosis research and surgery will continue to have a lasting impact on modern society.